BMC Chemistry

Table 2 Druglikeness/ADMET prediction of the most potent compounds 4a–d, 4g, and 4m

From: Design, synthesis, in vitro, and in silico biological evaluations of coumarin-indole hybrids as new anti-α-glucosidase agents

Druglikeness/ADME^a/T	Compound
Druglikeness/ADME^a/T	4a	4b	4c	4d	4g	4m
Rule of Five^b	Suitable	Suitable	Suitable	Suitable	Suitable	Suitable
Caco2	29.7795	28.7663	40.7159	33.0844	23.5917	21.1337
HIA	93.264991	93.395854	93.287718	94.203919	93.27596	92.47756
BBB	6.36078	7.14551	4.50444	7.41116	6.80879	0.948237
Skin_Permeability	− 3.39577	− 3.20105	− 3.36115	− 2.65212	− 3.61849	− 3.41006
Ames_test	Mutagen	Mutagen	Mutagen	Non-mutagen	Mutagen	Mutagen
Carcino_Mouse	Negative	Negative	Negative	Negative	Negative	Negative
Carcino_Rat	Negative	Negative	Negative	Positive	Negative	Positive
hERG_inhibition	High risk	High risk	High risk	High risk	High risk	High risk

^aThe recommended ranges for Caco2: < 25 poor, > 500 great, HIA: > 80% is high < 25% is poor, BBB = − 3.0 to 1.2, and Skin_Permeability = − 8.0 to − 1.0
^b MW ≤ 500, HBD ≤ 5, HBA ≤ 10 and Clog P ≤ 5

Back to article page

ISSN: 2661-801X

Contact us

Submission enquiries: bmcchemistry@biomedcentral.com
General enquiries: ORSupport@springernature.com